Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Sohini Mondal

What Are Wall Street Analysts' Target Price for Henry Schein Stock?

Valued at a market cap of $8.9 billion, Henry Schein, Inc. (HSIC) is a distributor of healthcare products and services, including vaccines, pharmaceuticals, financial services, and equipment. This New York-based company operates through two segments: Health Care Distribution and Technology and Value-Added Services.

Shares of this healthcare products maker have significantly underperformed the broader market over the past 52 weeks. HSIC has declined 8.8% over this time frame, while the broader S&P 500 Index ($SPX) has rallied 28.3%. In 2024, shares of HSIC dipped 7.8%, compared to SPX’s 17.6% gain on a YTD basis. 

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.